{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T22:57:32Z","timestamp":1777330652344,"version":"3.51.4"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T00:00:00Z","timestamp":1735171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Hidradenitis suppurativa (HS) is a chronic inflammatory cutaneous disease characterized by recurrent painful nodules, abscesses and sinus tracts on the apocrine gland-bearing skin. The role of sex hormones in the pathogenesis as well as the use of hormonal treatment in the management of HS is still debated. We performed a retrospective cohort study, including 183 patients, to assess the influence of the combined oral contraceptive (oestrogen\u2013progesterone COC) on HS onset and disease severity. Univariable and multivariable analyses highlighted that the patients undergoing COC therapy had a later onset of HS, more precisely 9.81\u2005years after the patients who have not received COC, independently of body mass index, family history, smoking, acne, age of menarche and concomitant gynaecological disorders. This study suggests that COC use could influence the development and the progression of HS and supports the key role of sex hormones in the pathogenesis of the disease.<\/jats:p>","DOI":"10.1093\/ced\/llae540","type":"journal-article","created":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T08:31:52Z","timestamp":1735201912000},"page":"1002-1005","source":"Crossref","is-referenced-by-count":3,"title":["The influence of hormonal combined contraceptive in\u00a0the\u00a0onset of hidradenitis suppurativa: a retrospective cohort study"],"prefix":"10.1093","volume":"50","author":[{"given":"Elisa","family":"Molinelli","sequence":"first","affiliation":[{"name":"Dermatological Unit, Department of Clinical and Molecular Sciences, Polytechnic Marche University , Ancona ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8052-9324","authenticated-orcid":false,"given":"Edoardo","family":"De Simoni","sequence":"additional","affiliation":[{"name":"Dermatological Unit, Department of Clinical and Molecular Sciences, Polytechnic Marche University , Ancona ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Luisa","family":"Dragonetti","sequence":"additional","affiliation":[{"name":"Dermatological Unit, Department of Clinical and Molecular Sciences, Polytechnic Marche University , Ancona ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Belleggia","sequence":"additional","affiliation":[{"name":"Dermatological Unit, Department of Clinical and Molecular Sciences, Polytechnic Marche University , Ancona ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Maurizi","sequence":"additional","affiliation":[{"name":"Dermatological Unit, Department of Clinical and Molecular Sciences, Polytechnic Marche University , Ancona ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisy","family":"Gambini","sequence":"additional","affiliation":[{"name":"Dermatological Unit, Department of Clinical and Molecular Sciences, Polytechnic Marche University , Ancona ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annamaria","family":"Offidani","sequence":"additional","affiliation":[{"name":"Dermatological Unit, Department of Clinical and Molecular Sciences, Polytechnic Marche University , Ancona ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oriana","family":"Simonetti","sequence":"additional","affiliation":[{"name":"Dermatological Unit, Department of Clinical and Molecular Sciences, Polytechnic Marche University , Ancona ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,12,26]]},"reference":[{"key":"2025042411073608500_llae540-B1","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1111\/bjd.19337","article-title":"Efficacy and safety of topical resorcinol 15% as long-term treatment of mild-to-moderate hidradenitis suppurativa: a valid alternative to clindamycin in the panorama of antibiotic resistance","volume":"183","author":"Molinelli","year":"2020","journal-title":"Br J Dermatol"},{"key":"2025042411073608500_llae540-B2","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jaad.2020.04.092","article-title":"Efficacy of oral zinc and nicotinamide as maintenance therapy for mild\/moderate hidradenitis suppurativa: a controlled retrospective clinical study","volume":"83","author":"Molinelli","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"2025042411073608500_llae540-B3","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/ced.14388","article-title":"Lymecycline vs. clindamycin plus rifampicin in hidradenitis suppurativa treatment: clinical and ultrasonography evaluation","volume":"46","author":"Caposiena Caro","year":"2021","journal-title":"Clin Exp Dermatol"},{"key":"2025042411073608500_llae540-B4","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/jdv.16677","article-title":"Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life","volume":"35","author":"Nguyen","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025042411073608500_llae540-B5","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11154-016-9328-5","article-title":"Evidence-based approach to the treatment of hidradenitis suppurativa\/acne inversa, based on the European guidelines for hidradenitis suppurativa","volume":"17","author":"Gulliver","year":"2016","journal-title":"Rev Endocr Metab Disord"},{"key":"2025042411073608500_llae540-B6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jaad.2019.02.068","article-title":"North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian Hidradenitis Suppurativa Foundations. Part II: topical, intralesional, and systemic medical management","volume":"81","author":"Alikhan","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"2025042411073608500_llae540-B7","first-page":"868","article-title":"S2k guideline for the treatment of hidradenitis suppurativa\/acne inversa\u00a0\u2013\u200c\u00a0short version","volume":"22","author":"Zouboulis","year":"2024","journal-title":"J Dtsch Dermatol Ges"},{"key":"2025042411073608500_llae540-B8","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s11154-016-9366-z","article-title":"Hidradenitis suppurativa\/acne inversa: an endocrine skin disorder?","volume":"17","author":"Karagiannidis","year":"2016","journal-title":"Rev Endocr Metab Disord"},{"key":"2025042411073608500_llae540-B9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s40257-020-00557-5","article-title":"Hormonal contraceptives and dermatology","volume":"22","author":"Williams","year":"2021","journal-title":"Am J Clin Dermatol"},{"key":"2025042411073608500_llae540-B10","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/ced\/llad385","article-title":"Hidradenitis suppurativa disease control associated with type of hormonal contraceptive use","volume":"49","author":"Huang","year":"2024","journal-title":"Clin Exp Dermatol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llae540\/61275851\/llae540.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/50\/5\/1002\/61275851\/llae540.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/50\/5\/1002\/61275851\/llae540.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T15:07:46Z","timestamp":1745507266000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/50\/5\/1002\/7932669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,26]]},"references-count":10,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,12,26]]},"published-print":{"date-parts":[[2025,4,24]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llae540","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5]]},"published":{"date-parts":[[2024,12,26]]}}}